Clinical Trials Directory

Trials / Completed

CompletedNCT02254629

The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients

The Effects of Laxative-probiotic Sequential Treatment on the Symptoms and Fecal Microbiota in the IBS Patients.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

the laxative-probiotic sequential treatment might reduce the symptoms of IBS and alter the fecal microbiota of the patients in a more robust manner .

Detailed description

Probiotics can regulate intestinal immunity, repair mucosal barrier, and reportedly exert therapeutic effects on IBS patients. The laxatives could also alter the gut microflora significantly, thus the laxative-probiotic sequential treatment might affect the symptoms and the composition of fecal microbiota in the IBS patients in a more robust manner .

Conditions

Interventions

TypeNameDescription
DRUGProbiotic Clostridium Butyricumprobiotic:2 tablets/ times, 3 times / day for 2 weeks
DRUGLaxative Polyethylene Glycollaxative:2000 ml.

Timeline

Start date
2014-07-01
Primary completion
2015-08-01
Completion
2016-07-01
First posted
2014-10-02
Last updated
2016-08-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02254629. Inclusion in this directory is not an endorsement.